KINGWORLD (01110) Sets 31 Mar 2026 Board Meeting to Review FY 2025 Results and Final Dividend Proposal
Bulletin Express
Mar 18
Kingworld Medicines Group Limited (KINGWORLD, 01110) has scheduled a board meeting for 31 March 2026 at its Hong Kong headquarters (Unit 613, 6/F, Goodluck Industrial Centre, 808 Lai Chi Kok Road, Kowloon).
The Board will consider and approve the audited annual results for the financial year ended 31 December 2025. Directors will also deliberate on the recommendation of a final dividend, if any, and address other corporate matters.
As of the notice date (18 March 2026), the Board comprises three executive directors—Zhao Li Sheng (Chairman), Chan Lok San and Zhou Xuhua—and three independent non-executive directors—Duan Jidong, Wong Cheuk Lam and Dr. Chu Xiaoping.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.